These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 8457221)
1. Cancer in systemic sclerosis. Abu-Shakra M; Guillemin F; Lee P Arthritis Rheum; 1993 Apr; 36(4):460-4. PubMed ID: 8457221 [TBL] [Abstract][Full Text] [Related]
2. [Cancers in systemic sclerosis : risk factors, impact on survival and literature review]. Catano J; Guedon A; Riviere S; Carrat F; Mahevas T; Fain O; Mekinian A Rev Med Interne; 2019 Oct; 40(10):637-644. PubMed ID: 31255252 [TBL] [Abstract][Full Text] [Related]
3. Incidence and the risk factor of malignancy in Japanese patients with systemic sclerosis. Hashimoto A; Arinuma Y; Nagai T; Tanaka S; Matsui T; Tohma S; Endo H; Hirohata S Intern Med; 2012; 51(13):1683-8. PubMed ID: 22790126 [TBL] [Abstract][Full Text] [Related]
4. Cancer risk among patients with systemic sclerosis: a nationwide population study in Taiwan. Kuo CF; Luo SF; Yu KH; Chou IJ; Tseng WY; Chang HC; Fang YF; Chiou MJ; See LC Scand J Rheumatol; 2012 Feb; 41(1):44-9. PubMed ID: 22150162 [TBL] [Abstract][Full Text] [Related]
5. Incidence of cancer among patients with systemic sclerosis in Korea: results from a single centre. Kang KY; Yim HW; Kim IJ; Yoon JU; Ju JH; Kim HY; Park SH Scand J Rheumatol; 2009; 38(4):299-303. PubMed ID: 19308805 [TBL] [Abstract][Full Text] [Related]
7. Systemic sclerosis and malignancy: a review of the literature. Wooten M South Med J; 2008 Jan; 101(1):59-62. PubMed ID: 18176294 [TBL] [Abstract][Full Text] [Related]
8. Incidence, Risk Factors, and Outcomes of Cancer in Systemic Sclerosis. Morrisroe K; Hansen D; Huq M; Stevens W; Sahhar J; Ngian GS; Ferdowsi N; Hill C; Roddy J; Walker J; Proudman S; Nikpour M Arthritis Care Res (Hoboken); 2020 Nov; 72(11):1625-1635. PubMed ID: 31539207 [TBL] [Abstract][Full Text] [Related]
9. Breast cancer in systemic sclerosis: results of a cross-linkage of an Italian Rheumatologic Center and a population-based Cancer Registry and review of the literature. Colaci M; Giuggioli D; Vacchi C; Lumetti F; Iachetta F; Marcheselli L; Federico M; Ferri C Autoimmun Rev; 2014 Feb; 13(2):132-7. PubMed ID: 24103404 [TBL] [Abstract][Full Text] [Related]
10. Lung cancer in scleroderma: results from an Italian rheumatologic center and review of the literature. Colaci M; Giuggioli D; Sebastiani M; Manfredi A; Vacchi C; Spagnolo P; Cerri S; Luppi F; Richeldi L; Ferri C Autoimmun Rev; 2013 Jan; 12(3):374-9. PubMed ID: 22743031 [TBL] [Abstract][Full Text] [Related]
11. Incidence of lung cancer in patients with systemic sclerosis treated with extracorporeal photopheresis. Topuzoglu S; Knobler R; Movadat O; Petkov V; Foedinger D; Just U; Pehamberger H; Jantschitsch C Photodermatol Photoimmunol Photomed; 2015 Jul; 31(4):175-83. PubMed ID: 25495608 [TBL] [Abstract][Full Text] [Related]
12. Determinants of morbidity and mortality of systemic sclerosis in Canada. Al-Dhaher FF; Pope JE; Ouimet JM Semin Arthritis Rheum; 2010 Feb; 39(4):269-77. PubMed ID: 18706680 [TBL] [Abstract][Full Text] [Related]
13. Cancer incidence in systemic sclerosis: meta-analysis of population-based cohort studies. Onishi A; Sugiyama D; Kumagai S; Morinobu A Arthritis Rheum; 2013 Jul; 65(7):1913-21. PubMed ID: 23576072 [TBL] [Abstract][Full Text] [Related]
14. Standardized incidence ratios and risk factors for cancer in patients with systemic sclerosis: Data from the Spanish Scleroderma Registry (RESCLE). Carbonell C; Marcos M; Guillén-Del-Castillo A; Rubio-Rivas M; Argibay A; Marín-Ballvé A; Rodríguez-Pintó I; Baldà-Masmiquel M; Callejas-Moraga E; Colunga D; Sáez-Comet L; González-Echávarri C; Ortego-Centeno N; Marí-Alfonso B; Vargas-Hitos JA; Todolí-Parra JA; Trapiella L; Herranz-Marín MT; Freire M; Castro-Salomó A; Perales-Fraile I; Madroñero-Vuelta AB; Sánchez-García ME; Ruiz-Muñoz M; González-García A; Sánchez-Redondo J; de-la-Red-Bellvis G; Fernández-Luque A; Muela-Molinero A; Lledó GM; Tolosa-Vilella C; Fonollosa-Pla V; Chamorro AJ; Simeón-Aznar CP; Autoimmun Rev; 2022 Oct; 21(10):103167. PubMed ID: 35931315 [TBL] [Abstract][Full Text] [Related]
15. Increased malignancies in our Waikato cohort of patients with systemic sclerosis. Rees MS; Frampton C; White DHN; Solanki KK Int J Rheum Dis; 2021 Apr; 24(4):555-561. PubMed ID: 33751804 [TBL] [Abstract][Full Text] [Related]
16. A cohort study of cancer incidence in systemic sclerosis. Derk CT; Rasheed M; Artlett CM; Jimenez SA J Rheumatol; 2006 Jun; 33(6):1113-6. PubMed ID: 16622904 [TBL] [Abstract][Full Text] [Related]
17. Incidence of lung cancer in systemic sclerosis. Peters-Golden M; Wise RA; Hochberg M; Stevens MB; Wigley FM J Rheumatol; 1985 Dec; 12(6):1136-9. PubMed ID: 4093920 [TBL] [Abstract][Full Text] [Related]
19. Cancer and systemic sclerosis. An epidemiologic study. Roumm AD; Medsger TA Arthritis Rheum; 1985 Dec; 28(12):1336-40. PubMed ID: 4084328 [TBL] [Abstract][Full Text] [Related]
20. Risk factors for lung cancer in patients with scleroderma: a nested case-control study. Pontifex EK; Hill CL; Roberts-Thomson P Ann Rheum Dis; 2007 Apr; 66(4):551-3. PubMed ID: 16984943 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]